Literature DB >> 8519664

A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.

M E Christensen1, F Engbaek, M H Therkildsen, P Bretlau, E Nexø.   

Abstract

The EGF receptor is a transmembrane glycoprotein exerting mitogenic effects on epithelial cells. The purpose of the present study was to develop a sensitive enzyme-linked immunosorbent assay (ELISA) for determination of the epidermal growth factor receptor (EGFR) protein to examine whether the receptor was overexpressed in head and neck squamous cell carcinomas compared with the normal counterpart, and to establish whether clinicopathological correlations were present by investigating a broad spectrum of parameters (tumour size, clinical stage, positive lymph nodes, tumour site, histological grade, keratinisation, preoperative irradiation and clinical outcome). The assay employs two commercially available monoclonal antibodies, both detecting protein epitopes. The material comprises 60 head and neck carcinomas, corresponding normal tissue and normal oral mucosa from healthy individuals. The study demonstrates significantly higher receptor levels in tumours compared with normal tissue (P < 0.002) and a range in tumours and normal tissues of 0.4-10.5 and 0.1-4.3 nmol g-1 membrane protein respectively. Quantitation of receptors in normal mucosa emphasises the importance of using the patients' corresponding normal tissue, because using the patients' mucosa resulted in 83% overexpression, while using normal mucosa from healthy individuals only demonstrated overexpression in 50% of cases. No significant clinicopathological correlations could be established, although the mean values for EGFR increased with tumour size and advanced clinical stage. Furthermore, the prognostic value concerning disease-free survival, recurrence and the time interval for recurrence were investigated but no significance could be demonstrated. In conclusion, the investigation supports the theory of overexpression of EGFR protein as a common motif for malignant epithelial tumours, but limitations in interpretations are demonstrated and discussed further.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8519664      PMCID: PMC2034104          DOI: 10.1038/bjc.1995.534

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  54 in total

1.  Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin.

Authors:  D P SLAUGHTER; H W SOUTHWICK; W SMEJKAL
Journal:  Cancer       Date:  1953-09       Impact factor: 6.860

2.  Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle.

Authors:  M R Stampfer; C H Pan; J Hosoda; J Bartholomew; J Mendelsohn; P Yaswen
Journal:  Exp Cell Res       Date:  1993-09       Impact factor: 3.905

Review 3.  Membrane-anchored growth factors.

Authors:  J Massagué; A Pandiella
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

4.  Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas.

Authors:  M E Christensen; M H Therkildsen; B L Hansen; H Albeck; G N Hansen; P Bretlau
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

Review 5.  The role of peptide growth factors in head and neck carcinoma.

Authors:  J R Grandis; D J Tweardy
Journal:  Otolaryngol Clin North Am       Date:  1992-10       Impact factor: 3.346

6.  Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family.

Authors:  R Sasada; Y Ono; Y Taniyama; Y Shing; J Folkman; K Igarashi
Journal:  Biochem Biophys Res Commun       Date:  1993-02-15       Impact factor: 3.575

7.  Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor alpha.

Authors:  S Huang; J M Trujillo; S Chakrabarty
Journal:  Int J Cancer       Date:  1992-12-02       Impact factor: 7.396

8.  Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.

Authors:  G D Plowman; J M Culouscou; G S Whitney; J M Green; G W Carlton; L Foy; M G Neubauer; M Shoyab
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay--a retrospective study.

Authors:  F Spyratos; P M Martin; K Hacène; C Andrieu; S Romain; J L Floiras; H Magdelénat
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

10.  Oncogenes in head and neck cancer.

Authors:  J C Irish; A Bernstein
Journal:  Laryngoscope       Date:  1993-01       Impact factor: 3.325

View more
  6 in total

Review 1.  Oral field cancerization: current evidence and future perspectives.

Authors:  Punnya V Angadi; J K Savitha; Sanjay S Rao; Y Sivaranjini
Journal:  Oral Maxillofac Surg       Date:  2012-02-22

2.  The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.

Authors:  Boe Sandahl Sørensen; Niels Tørring; Mustafa Vakur Bor; Ebba Nexø
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

3.  Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia.

Authors:  Nitin Nitin; Kelsey J Rosbach; Adel El-Naggar; Michelle Williams; Ann Gillenwater; Rebecca R Richards-Kortum
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

Review 4.  Oral field cancerization: an update on current concepts.

Authors:  Meenakshi Mohan; Nithya Jagannathan
Journal:  Oncol Rev       Date:  2014-06-30

5.  Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis.

Authors:  P Pfeiffer; E Nexø; S M Bentzen; P P Clausen; K Andersen; C Rose
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

6.  Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis.

Authors:  I-H Chen; J T Chang; C-T Liao; H-M Wang; L-L Hsieh; A-J Cheng
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.